GCP
PRNB

GSA Capital Partners’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

GSA Capital Partners’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,861
Closed -$231K – 1472
2020
Q2 		$231K Buy
+3,861
New +$239K 0.13% 275

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

GSA Capital Partners's PRNB Position: Q3 2020 in Review

GSA Capital Partners sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 3,861 shares — an estimated $231K sold.

GSA Capital Partners first reported a position in PRNB in Q2 2020 and held it in 1 quarter. The position peaked at $231K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • GSA Capital Partners reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • GSA Capital Partners sold 3,861 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $231K.
  • GSA Capital Partners first reported a position in Principia Biopharma Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • GSA Capital Partners's Principia Biopharma Inc. Common Stock position peaked at $231K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on GSA Capital Partners's 13F filing for Q3 2020, filed 6 Nov 2020.